Literature DB >> 10814787

Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures.

Y Kitamura1, T Taniguchi, H Kimura, Y Nomura, P J Gebicke-Haerter.   

Abstract

Interleukin-4 (IL-4) likely is one of the key players in the concert of immunosuppressive factors in brain. Therefore, influences of the cytokine on mRNA expression of endogenous mediators of inflammation, such as cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor-alpha (TNF-alpha), interferon-inducible protein 10 (IP-10), interleukin-3 receptor-beta (IL-3R-beta), and of another antiinflammatory cytokine, IL-10, have been evaluated in the present study by semi-quantitative RT-PCR. Primary rat mixed glial cultures and isolated microglial cells, the resident immunocytes of the brain, have been used as rich sources of these mRNAs in response to the bacterial cell wall component lipopolysaccharide (LPS). Time-course studies showed peak levels of LPS-increased mRNAs at approximately 4 h. Interestingly, IL-10 mRNA was elevated also upon the LPS-stimulus. IL-4, given 30 min before LPS, inhibited increases of all mRNAs significantly, including IL-10 mRNA. IL-4, however, induced peroxisome proliferator-activated receptor (PPAR)-gamma in cultured microglia. This induction was completely inhibited by simultaneous administration of LPS. The data confirms IL-4 as an important antiinflammatory cytokine and gives some idea of cross-talk between intracellular signaling evoked by pro- and antiinflammatory substances.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814787     DOI: 10.1016/s0165-5728(00)00239-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

Review 1.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

2.  Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.

Authors:  Javier A Soria; Daniela S Arroyo; Emilia A Gaviglio; Maria C Rodriguez-Galan; Ji Ming Wang; Pablo Iribarren
Journal:  Neurobiol Dis       Date:  2011-05-23       Impact factor: 5.996

Review 3.  Macrophages make me sick: how macrophage activation states influence sickness behavior.

Authors:  Morgan L Moon; Leslie K McNeil; Gregory G Freund
Journal:  Psychoneuroendocrinology       Date:  2011-08-19       Impact factor: 4.905

4.  Increased grp78 transcription is correlated to reduced tlr4 transcription in patients surviving sepsis.

Authors:  R C Stan; C Pinto Bonin; R Porto; F G Soriano; M M de Camargo
Journal:  Clin Exp Immunol       Date:  2019-08-06       Impact factor: 4.330

5.  Age-related neuroinflammatory changes negatively impact on neuronal function.

Authors:  Marina A Lynch
Journal:  Front Aging Neurosci       Date:  2010-01-04       Impact factor: 5.750

6.  IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury.

Authors:  Ashley M Fenn; Jodie C E Hall; John C Gensel; Phillip G Popovich; Jonathan P Godbout
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

Review 7.  Cannabinoids and neuroinflammation.

Authors:  Lisa Walter; Nephi Stella
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

Review 8.  Microglia and spinal cord synaptic plasticity in persistent pain.

Authors:  Sarah Taves; Temugin Berta; Gang Chen; Ru-Rong Ji
Journal:  Neural Plast       Date:  2013-08-18       Impact factor: 3.599

Review 9.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

10.  Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.

Authors:  Antonietta Bernardo; Luisa Minghetti
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.